Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia

Anesthesiology

Volumn 101, Issue 6, 2004, Pages 1400-1408

  Gottrup, Hanne ^a,c   Juhl, Gitte ^a   Kristensen, Anders D ^a   Lai, Robert ^b   Chizh, Boris A ^b   Brown, John ^b   Bach, Flemming W ^a   Jensen, Troels S ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b GLAXOSMITHKLINE   (United Kingdom)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; GABAPENTIN; PLACEBO;

ADULT; ALLODYNIA; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MODEL; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG ERUPTION; DRUG SCREENING; DRUG UTILIZATION; EXPERIMENT; FATIGUE; FOREARM; HEADACHE; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; MALE; MENTAL CONCENTRATION; MUSCLE WEAKNESS; NERVOUSNESS; NORMAL HUMAN; PAIN; PARONIRIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIZATION; SIDE EFFECT; SOMNOLENCE; TITRIMETRY;

EID: 9444255163     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200412000-00021     Document Type: Article

References (61)

1. McQuay HJ, Moore RA: An Evidence-Based Resource for Pain Relief. Oxford, Oxford University Press, 1998
2. Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999; 83:389-400
3. Woolf CJ, Bennett GJ, Doherty M, Dubner R, Kidd B, Koltzenburg M, Lipton R, Loeser JD, Payne R, Torebjork E: Towards a mechanism-based classification of pain? Pain 1998; 77:227-9
4. Jensen TS, Gottrup H, Sindrup SH, Bach FW: The clinical picture of neuropathic pain. Eur J Pharmacol 2001; 429:1-11
5. Woolf CJ, Max MB: Mechanism-based pain diagnosis: Issues for analgesic drug development. ANESTHESIOLOGY 2001; 95:241-9
6. Scholz J, Woolf CJ: Can we conquer pain? Nat Neurosci 2002; 5(suppl):1062-7
7. Jensen TS, Baron R: Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 2003; 102:1-8
8. Bridges D, Thompson SWN, Rice ASC: Mechanisms of neuropathic pain. Br J Anaesth 2001; 87:12-26
9. Devor M: The pathophysiology of damaged peripheral nerves, The Textbook of Pain. Edited by Wall PD, Melzack R. Edinburgh, Churchill Livingstone, 1994, pp 79-112
10. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science 2000; 288:1765-9
11. Culp WJ, Ochoa J, Cline M, Dotson R: Heat and mechanical hyperalgesia induced by capsaicin: Cross modality threshold modulation in human C nociceptors. Brain 1989; 112(pt 5):1317-31
12. Pedersen JL, Kehlet H: Secondary hyperalgesia to heat stimuli after burn injury in man. Pain 1998; 76:377-84
13. Pedersen JL, Kehlet H: Hyperalgesia in a human model of acute inflammatory pain: A methodological study. Pain 1998; 74:139-51
14. Petersen KL, Rowbotham MC: A new human experimental pain model: The heat/capsaicin sensitization model. Neuroreport 1999; 10:1511-6
15. Raja SN, Campbell JN, Meyer RA: Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain 1984; 107:1179-88
16. Simone DA, Baumann TK, Lamotte RH: Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 1989; 38:99-107
17. Lamotte RH, Shain CN, Simone DA, Tsai EF: Neurogenic hyperalgesia: Psychophysical studies of underlying mechanisms. J Neurophysiol 1991; 66:190-211
18. Gottrup H, Hansen PO, Arendt-Nielsen L, Jensen TS: Differential effects of systemically administered ketamine and lidocaine on dynamic and static hyperalgesia induced by intradermal capsaicin in humans. Br J Anaesth 2000; 84:155-62
19. Koppert W, Zeck S, Blunk JA, Schmelz M, Likar R, Sittl R: The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and flare reaction. Anesth Analg 1999; 89:1521-7
20. Park KM, Max MB, Robinovitz E, Gracely RH, Bennett GJ: Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. Pain 1995; 63:163-72
21. Wallace MS, Laitin S, Licht D, Yaksh TL: Concentration - effect relations for intravenous lidocaine infusions in human volunteers: Effects on acute sensory thresholds and capsaicin-evoked hyperpathia, ANESTHESIOLOGY 1997; 86:1262-72
22. Dirks J, Petersen KL, Rowbotham MC: Gabapentin suppresses cutaneous hyperalgesia following heat-capsaicin sensitization. ANESTHESIOLOGY 2002; 97:102-7
23. Backonja M, Glanzman RL: Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials. Clin Ther 2003; 25:81-104
24. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA 1998; 280:1831-6
25. Rice AS, Maton S: Gabapentin in postherpetic neuralgia: A randomised, double blind, placebo controlled study. Pain 2001; 94:215-24
26. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L: Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 1998; 280:1837-42
27. Serpell MG, Neuropathic Pain Study Group: Gabapentin in neuropathic pain syndromes: A randomised, double-blind, placebo-controlled trial. Pain 2002; 99:557-66
28. Simone DA, Sorkin LS, Oh U, Chung JM, Owens C, Lamotte RH, Willis WD: Neurogenic hyperalgesia: Central neural correlates in responses of spinothalamic tract neurons. J Neurophysiol 1991; 66:228-46
29. Gottrup H, Kristensen AD, Bach FW, Jensen TS: Aftersensations in experimental and clinical hypersensitivity. Pain 2003; 103:57-64
30. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997; 389:816-24
31. Yeomans DC, Pirec V, Proudfit HK: Nociceptive responses to high and low rates of noxious cutaneous heating are mediated by different nociceptors in the rat: Behavioral evidence. Pain 1996; 68:133-40
32. Baumann TK, Simone DA, Shain CN, Lamotte RH: Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol 1991; 66:212-27
33. Ali Z, Meyer RA, Campbell JN: Secondary hyperalgesia to mechanical but not heat stimuli following a capsaicin injection in hairy skin. Pain 1996; 68:401-11
34. Petersen KL, Fields HL, Brennum J, Sandroni P, Rowbotham MC: Capsaicin evoked pain and allodynia in post-herpetic neuralgia. Pain 2000; 88:125-33
35. Sieweke N, Birkiein F, Riedl B, Neundorfer B, Handwerker HO: Patterns of hyperalgesia in complex regional pain syndrome. Pain 1999; 80:171-7
36. Eisenach JC, Hood DD, Curry R: Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. ANESTHESIOLOGY 2002; 96:29-34
37. Field MJ, McCleary S, Hughes J, Singh L: Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999; 80:391-8
38. Field MJ, Holloman EF, McCleary S, Hughes J, Singh L: Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. J Pharmacol Exp Ther 1997; 282:1242-6
39. Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L: Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 1997; 121:1513-22
40. Pan HL, Eisenach JC, Chen SR: Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 1999; 288:1026-30
41. Field MJ, Hughes J, Singh L: Further evidence for the role of the alpha(2)delta subunit of voltage dependent calcium channels in models of neuropathic pain. Br J Pharmacol 2000; 131:282-6
42. Rose MA, Kam PC: Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002; 57:451-62
43. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, Singh L: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998; 29:233-49
44. Witting N, Svensson P, Arendt-Nielsen L, Jensen TS: Repetitive intradermal capsaicin: Differential effect on pain and areas of allodynia and punctate hyperalgesia. Somatosens Mot Res 2000; 17:5-12
45. Attal N, Brasseur L, Parker F, Chauvin M, Bouhassira D: Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: A pilot study. Eur Neurol 1998; 40:191-200
46. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, Handwerker HO: Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 2000; 11:645-8
47. Felsby S, Nielsen J, Arendt-Nielsen L, Jensen TS: NMDA receptor blockade in chronic neuropathic pain: A comparison of ketamine and magnesium chloride. Pain 1996; 64:283-91
48. Mendell LM: Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 1966; 16:316-32
49. Herrero JF, Laird JM, Lopez-Garcia JA: Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 2000; 61:169-203
50. Eide PK, Jorum E, Stubhaug A, Bremnes J, Breivik H: Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58:347-54
51. Gottrop H, Nielsen J, Arendt-Nielsen L, Jensen TS: The relationship between sensory thresholds and mechanical hyperalgesia in nerve injury. Pain 1998; 75:321-9
52. Nikolajsen L, Hansen CL, Nielsen J, Keller J, Arendt-Nielsen L, Jensen TS: The effect of ketamine on phantom pain: A central neuropathic disorder maintained by peripheral input. Pain 1996; 67:69-77
53. Chizh BA, Scheede M, Schlutz H: Antinociception and (R,S)-alpha-amino-3- hydroxy-5-methyl-4-isoxazole propionic acid antagonism by gabapentin in the rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:197-200
54. Woolf CJ: Windup and central sensitization are not equivalent. Pain 1996; 66:105-8
55. Dirks J, Fredensborg BB, Christensen D, Fomsgaard JS, Flyger H, Dahl JB: A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy. ANESTHESIOLOGY 2002; 97:560-4
56. Werner MU, Perkins FM, Holte K, Pedersen JL, Kehlet H: Effects of gabapentin in acute inflammatory pain in humans. Reg Anesth Pain Med 2001; 26:322-8
57. Simone DA, Ngeow JY, Putterman GJ, Lamotte RH: Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res 1987; 418:201-3
58. Dirks J, Fabricius P, Petersen KL, Rowbotham MC, Dahl JB: The effect of systemic lidocaine on pain and secondary hyperalgesia associated with the heat/capsaicin sensitization model in healthy volunteers. Anesth Analg 2000; 91:967-72
59. Bach FW, Jensen TS, Kastrup J, Stigsby B, Dejgard A: The effect of intravenous lidocaine on nociceptive processing in diabetic neuropathy. Pain 1990; 40:29-34
60. Kastrup J, Petersen P, Dejgard A, Angelo HR, Hilsted J: Intravenous lidocaine infusion: A new treatment of chronic painful diabetic neuropathy? Pain 1987; 28:69-75
61. Rowbotham MC, Reisner-Keller LA, Fields HL: Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology 1991; 41: 1024-8